HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use
- 14 May 2009
- journal article
- research article
- Published by Informa UK Limited in AIDS Care
- Vol. 21 (5), 655-663
- https://doi.org/10.1080/09540120802459762
Abstract
Mental illness (MI) and illicit drug use (DU) frequently co-occur. We sought to determine the individual and combined effects of MI and DU on highly active antiretroviral therapy (HAART) receipt and HIV-RNA suppression among individuals engaged in HIV care. Using 2004 data from the HIV Research Network (HIVRN), we performed a cross-sectional study of HIV-infected patients followed at seven primary care sites. Outcomes of interest were HAART receipt and virological suppression, defined as an HIV-RNA <400 copies/ml. Independent variables of interest were: (1) MI/DU; (2) DU only; (3) MI only; and (4) Neither. We used chi-squared analysis for comparison of categorical variables, and logistic regression to adjust for age, race, sex, frequency of outpatient visits, years in clinical care, CD4 nadir, and study site. During 2004, 10,284 individuals in the HIVRN were either on HAART or HAART eligible defined as a CD4 cell count ≤350. Nearly half had neither MI nor DU (41%), 22% MI only, 15% DU only, and 22% both MI and DU. In multivariate analysis, co-occurring MI/DU was associated with the lowest odds of HAART receipt (Adjusted Odds Ratio: 0.63 (95% CI: (0.55–0.72]), followed by those with DU only (0.75(0.63–0.87)), compared to those with neither. Among those on HAART, concurrent MI/DU (0.66 (0.58–0.75)), DU only (0.77 (0.67–0.88)), were also associated with a decreased odds of HIV-RNA suppression compared to those with neither. MI only was not associated with a statistically significant decrease in HAART receipt (0.93(0.81–1.07)) or viral suppression (0.93 (0.82–1.05)) compared to those with neither. Post-estimation testing revealed a significant difference between those with MI/DU and DU only, and MI/DU and MI only. Co-occurring MI and DU is associated with lower HAART receipt and viral suppression compared to individuals with either MI or DU or neither. Integrating HIV, substance abuse, and mental healthcare may improve outcomes in this population.Keywords
This publication has 31 references indexed in Scilit:
- A review of barriers and facilitators of HIV treatment among injection drug usersAIDS, 2008
- Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug useGeneral Hospital Psychiatry, 2007
- Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive womenDrug and Alcohol Dependence, 2007
- Adherence to Antidepressant Treatment Among Privately Insured Patients Diagnosed With DepressionMedical Care, 2007
- Psychiatric Illness and Virologic Response in Patients Initiating Highly Active Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Improving Care for Depression in Patients With Comorbid Substance MisuseAmerican Journal of Psychiatry, 2006
- Predictors of Virologic Failure and Resistance in HIV-Infected Patients Treated with Nevirapine- or Efavirenz-Based Antiretroviral TherapyClinical Infectious Diseases, 2004
- Literature on integrated HIV care: a reviewAIDS Care, 2004
- Co-occurring Psychiatric Symptoms and Drug Dependence or Heavy Drinking Among HIV-Positive PeopleJournal of Psychoactive Drugs, 2003
- Predicting Medication Noncompliance After Hospital Discharge Among Patients With SchizophreniaPsychiatric Services, 2000